-28%

est. 2Y upside i

E-CommerceSeries B

Powering the animal health supply chain.

Rank

#3448

Sector

B2B E-commerce

Est. Liquidity

~4Y

Data Quality

Data: Low

Cautious outlook.

Last updated: July 3, 2026

Bull (10%)+47%

Exit multiple holds at 10x supported by an IPO window; revenue reaches $52M, common value nets to 46.8% upside after preference and dilution.

Base (45%)+5%

Multiple converges to 8x, revenue $52M, preference overhang limits common upside to 5.2% after dilution.

Bear (45%)-78%

Multiple compresses to 4x due to Chewy litigation and Covetrus competition, exit value $208M, preference leaves common with 78% loss.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

7650%

Total funding $153M vs estimated entry valuation $200M results in 76.5% preference overhang, common only participates above $153M exit.

Dilution Risk

high

Likely future capital raise inferred from $30M Series B in June 2025 and $153M total funding, assumed 20% dilution over 2 years.

Secondary Liquidity

none

No secondary market data or signals; illiquid private company.

Engineering 6 roles

Account Management 3 roles

Finance 3 roles

Growth and Marketing 3 roles

Design 2 roles

Sales and Retention 2 roles

Legal 1 role

View all 24 open roles at Vetcove

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Vetcove's data — designed to show you've done your homework.

  • 1

    How does Vetcove plan to differentiate against Chewy's and Covetrus's integrated offerings?

  • 2

    What is the current take rate and how are you increasing it without alienating vendors?

  • 3

    What is the current 409A valuation and what is the strike price for options?

Community

Valuation Sentiment

Our model estimates -28% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.